Immuron Ltd ADR
Price & Volume
Stats
See more52W Range | $0.67-$2.39 |
Market Cap | $8.5M |
Shares Short | 31,975 |
Financials
See moreRevenue (12 Mos) | $7.2M |
Revenue Growth (YoY) | 29.3% |
Gross Profit (12 Mos) | $4.7M |
Diluted EPS | -$0.60 |
News
See moreYahoo Finance • 30 days ago
Immuron (IMRN) Struggles After Announcing Trial Results
Yahoo Finance • last month
Immuron New U.S. Department of Defense Award & Clinical Trial Update
Yahoo Finance • 2 months ago
Immuron IMM-529 IND approved by FDA
Yahoo Finance • 2 months ago
Immuron Announces Clinical Trial Update
About
CFO | Mr. Philip Allen Hains BBus(Acc), C.A., M.B.A. |
Address | 62 Lygon Street, Carlton, VIC, Australia, 3053 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |
